We are live on ! Find out more
PRVB

Provention Bio, Inc. Common Stock
PRVB

Delisted

PRVB was delisted on the 26th of April, 2023.

Back to rankings

182 hedge funds and large institutions have $1.47B invested in Provention Bio, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 76 funds opening new positions, 52 increasing their positions, 35 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more funds holding in top 10

Funds holding in top 10: 1 → 9 (+8)

208% more capital invested

Capital invested by funds: $477M → $1.47B (+$992M)

181% more first-time investments, than exits

New positions opened: 76 | Existing positions closed: 27

68% more call options, than puts

Call options by funds: $45.6M | Put options by funds: $27.1M

49% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 35

37% more funds holding

Funds holding: 133 → 182 (+49)

Holders
182
Holders Change
+49
Holders Change %
+36.84%
% of All Funds
2.9%
Holding in Top 10
9
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+800%
% of All Funds
0.14%
New
76
Increased
52
Reduced
35
Closed
27
Calls
$45.6M
Puts
$27.1M
Net Calls
+$18.5M
Net Calls Change
+$3.62M

Top Buyers

Rank Fund Capital Flow
1
PCM
Pentwater Capital Management
Florida
+$39.3M
2
UOC
UBS O'Connor
Illinois
+$36.7M
3
MF
Magnetar Financial
Illinois
+$18.6M
4
AAM
Alpine Associates Management
Florida
+$17.1M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$14.1M

Top Sellers

Rank Fund Capital Flow
1
SC
Sessa Capital
New York
-$75.3M
2
VA
VR Adviser
New York
-$11.8M
3
Verition Fund Management
Verition Fund Management
Connecticut
-$8.87M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$8.2M
5
Invesco
Invesco
Georgia
-$6.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
OR
76
Olympiad Research
Connecticut
$1.98M +$1.03M +82,305 New
VAM
77
Vazirani Asset Management
New York
$1.93M +$1M +80,000 New
1WM
78
1900 Wealth Management
Texas
$1.91M – – –
RA
79
Ramius Advisors
New York
$1.89M +$983K +78,356 New
Dimensional Fund Advisors
80
Dimensional Fund Advisors
Texas
$1.87M +$20.9K +1,666 +2%
KC
81
Kellner Capital
New York
$1.83M +$951K +75,800 New
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
82
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$1.81M +$941K +75,000 New
Marshall Wace
83
Marshall Wace
United Kingdom
$1.8M +$935K +74,500 New
RHJA
84
Rice Hall James & Associates
California
$1.74M -$1.38M -109,804 -60%
State of Wisconsin Investment Board
85
State of Wisconsin Investment Board
Wisconsin
$1.7M -$90.3K -7,196 -9%
Macquarie Group
86
Macquarie Group
Australia
$1.69M – – –
Russell Investments Group
87
Russell Investments Group
United Kingdom
$1.63M +$3.94K +314 +0.5%
HF
88
HRT Financial
New York
$1.61M +$841K +66,980 New
CSS
89
Cubist Systematic Strategies
Connecticut
$1.56M -$2.07M -164,859 -72%
FIA
90
FNY Investment Advisers
New York
$1.38M +$717K +57,172 New
MTCM
91
Mint Tower Capital Management
Netherlands
$1.37M +$713K +56,790 New
Deutsche Bank
92
Deutsche Bank
Germany
$1.35M +$220K +17,532 +45%
Wells Fargo
93
Wells Fargo
California
$1.35M -$47K -3,747 -6%
EGM
94
Engineers Gate Manager
New York
$1.21M +$227K +18,067 +56%
GAM
95
Gotham Asset Management
New York
$1.19M +$222K +17,704 +56%
SG Americas Securities
96
SG Americas Securities
New York
$1.19M +$487K +38,802 +375%
Simplex Trading
97
Simplex Trading
Illinois
$1.14M -$25.5K -2,035 -4%
FSI
98
Flow State Investments
Illinois
$1.07M +$556K +44,300 New
Invesco
99
Invesco
Georgia
$992K -$6.2M -493,716 -92%
Renaissance Technologies
100
Renaissance Technologies
New York
$991K +$516K +41,100 New
2 3
4
5 6

PRVB Hedge Fund Activity: Q1 2023 in Review

182 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Provention Bio, Inc. Common Stock (PRVB) for Q1 2023, worth a combined $1.47B — up 208% from $477M a quarter earlier.

Buyers outnumbered sellers: 76 funds opened new PRVB positions and 27 closed out — a net gain of 49 holders — while 52 added to existing stakes and 35 trimmed.

The largest buyer was Pentwater Capital Management, opening a new position worth an estimated $39.3M. The largest seller was Sessa Capital, cutting an estimated $75.3M.

  • 182 institutional investors held Provention Bio, Inc. Common Stock (PRVB) as of Q1 2023, up from 133 in Q4 2022.
  • Funds reported $1.47B of Provention Bio, Inc. Common Stock stock for Q1 2023, up 208% quarter-over-quarter.
  • 76 funds opened new Provention Bio, Inc. Common Stock positions in Q1 2023 and 27 closed out, a net change of +49 holders.
  • The largest Provention Bio, Inc. Common Stock buyer in Q1 2023 was Pentwater Capital Management, an estimated $39.3M added.
  • The largest Provention Bio, Inc. Common Stock seller in Q1 2023 was Sessa Capital, an estimated $75.3M sold.

Based on aggregated 13F filings for Q1 2023.